Residual Inflammatory Risk
Residual Inflammatory Risk - Related Videos
01:26
Residual Stresses
0 Views •
2024
Residual stresses reside in a structure even after removing the original stress inducer. This phenomenon often arises from varied plastic deformations across different parts of a structure. Consider a rod stretched beyond its yield point. It will not regain its original length due to permanent deformation. Even after load removal, the rod does not entirely lose stress because of uneven plastic deformations, resulting in residual stresses. The computation of these stresses in structures is...
01:07
Residual Plots
0 Views •
2023
A residual plot is a statistical representation of data used to analyze correlation and regression results. It helps verify the requirements for drawing specific conclusions about correlation and regression. To obtain the residual plot, first, the residual for each data value is calculated, which is simply the vertical distance between the observed and the predicted value obtained from the regression equation. When the residual values are plotted against the variable x, it is called a residual...
12:43
On-Chip Endothelial Inflammatory Phenotyping
0 Views •
Cited by 3 •
2012
Microfluidic flow chambers etched by photolithography and fabricated from PDMS are applied to probe functional outcomes associated with EC dysfunction and inflammation. In a representative experiment, the ability of differential shear stress to modulate monocytic cell adhesion to cytokine activated EC monolayers is demonstrated.
19:15
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
0 Views •
Cited by 40 •
2014
The NICU Network Neurobehavioral Scale (NNNS) was developed as an assessment for the at-risk infant. The purpose of this article is to describe the NNNS, provide video examples of the NNNS procedures and discuss the ways in which the exam has been used.
01:18
Residual Stresses in Bending
0 Views •
2024
In the study of elastoplastic members subjected to bending moments, understanding the loading and unloading phases is crucial for assessing material behavior and structural integrity. During the loading phase, as the bending moment increases, the material initially responds elastically, adhering to Hooke's Law, where stress is directly proportional to strain. When the load exceeds the yield strength, plastic deformation occurs, resulting in permanent strain and deformation that remains even...
FAQs
Inflammatory activity can continue within the vascular wall through the actions of immune cells and inflammatory mediators. These processes contribute to endothelial dysfunction, atherosclerotic plaque progression, and plaque instability. Their persistence helps explain why cardiovascular vulnerability may remain even after an important traditional risk factor, such as low-density lipoprotein cholesterol, has been treated.
Cholesterol-related risk reflects the contribution of lipid levels, whereas residual inflammatory risk reflects ongoing inflammatory activity that may remain after lipid management. The two processes can contribute to cardiovascular disease at the same time. This distinction supports a broader prevention strategy that considers inflammation alongside lipid lowering and other established interventions.
High-sensitivity C-reactive protein, commonly abbreviated as hsCRP, serves as a clinical marker of inflammatory activity relevant to cardiovascular risk. Its measurement can help identify patients whose inflammatory risk may remain clinically important despite standard preventive treatment. In this way, hsCRP supports risk assessment rather than replacing evaluation of traditional cardiovascular factors.
Clinicians can consider persistent inflammatory activity together with traditional cardiovascular risk factors and the effects of standard preventive therapy. A marker such as hsCRP may help identify patients who remain vulnerable to recurrent cardiovascular events. This added perspective can refine risk stratification by recognizing that controlled lipid levels do not necessarily capture all ongoing vascular risk.
It provides a clinical framework for asking whether targeting inflammation adds benefit beyond established prevention. Research can evaluate anti-inflammatory treatments in patients who remain at risk despite standard therapy, using cardiovascular vulnerability and inflammatory markers as relevant considerations. This approach separates the potential contribution of inflammation from the effects already addressed through lipid lowering.
The concept encourages investigation into how persistent vascular inflammation contributes to recurrent cardiovascular events and how best to identify patients affected by it. It also supports studies of strategies that target inflammation alongside lipid lowering and other interventions. Research in this area connects biological mechanisms, clinical markers, risk stratification, and evaluation of new preventive approaches.